TR201102810T2 - Tıbbi bir ürün ve tedavi - Google Patents

Tıbbi bir ürün ve tedavi

Info

Publication number
TR201102810T2
TR201102810T2 TR2011/02810T TR201102810T TR201102810T2 TR 201102810 T2 TR201102810 T2 TR 201102810T2 TR 2011/02810 T TR2011/02810 T TR 2011/02810T TR 201102810 T TR201102810 T TR 201102810T TR 201102810 T2 TR201102810 T2 TR 201102810T2
Authority
TR
Turkey
Prior art keywords
treatment
medical product
paracetamol
ibuprofen
osteoarthritis
Prior art date
Application number
TR2011/02810T
Other languages
English (en)
Turkish (tr)
Inventor
Campbell Atkinson Hartley
Original Assignee
Aft Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201102810(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Limited filed Critical Aft Pharmaceuticals Limited
Publication of TR201102810T2 publication Critical patent/TR201102810T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
TR2011/02810T 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi TR201102810T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14

Publications (1)

Publication Number Publication Date
TR201102810T2 true TR201102810T2 (tr) 2011-05-23

Family

ID=42106693

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2011/02810T TR201102810T2 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi
TR2019/06742T TR201906742T4 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2019/06742T TR201906742T4 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi.

Country Status (29)

Country Link
US (1) US20110166234A1 (enExample)
EP (1) EP2341900B1 (enExample)
JP (1) JP2012505830A (enExample)
KR (1) KR20110112279A (enExample)
CN (1) CN102215835A (enExample)
AU (1) AU2009304002B9 (enExample)
BR (1) BRPI0914086A2 (enExample)
CA (1) CA2735834C (enExample)
CH (1) CH702339B1 (enExample)
CL (1) CL2011000678A1 (enExample)
CO (1) CO6341553A2 (enExample)
CY (1) CY1122198T1 (enExample)
DK (1) DK2341900T3 (enExample)
ES (1) ES2725151T3 (enExample)
GB (1) GB2476418B (enExample)
HR (1) HRP20190891T1 (enExample)
HU (1) HUE043063T2 (enExample)
LT (1) LT2341900T (enExample)
MA (1) MA32635B1 (enExample)
MX (1) MX340662B (enExample)
MY (1) MY153932A (enExample)
NZ (1) NZ591496A (enExample)
PL (1) PL2341900T3 (enExample)
PT (1) PT2341900T (enExample)
RU (1) RU2487707C2 (enExample)
SI (1) SI2341900T1 (enExample)
TR (2) TR201102810T2 (enExample)
WO (1) WO2010044681A1 (enExample)
ZA (1) ZA201101752B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2431346C (en) 2004-07-07 2010-02-17 Aft Pharmaceuticals Ltd A combination composition comprising paracetamol and ibuprofen
PT2635269T (pt) 2010-11-04 2019-09-04 Aft Pharmaceuticals Ltd Composição de combinação
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
CA3236068A1 (en) 2017-07-10 2019-01-17 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
GB2431346C (en) * 2004-07-07 2010-02-17 Aft Pharmaceuticals Ltd A combination composition comprising paracetamol and ibuprofen
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
KR20110112279A (ko) 2011-10-12
EP2341900A4 (en) 2012-02-29
ES2725151T3 (es) 2019-09-19
HUE043063T2 (hu) 2019-07-29
ZA201101752B (en) 2012-02-29
RU2011111792A (ru) 2012-11-27
PL2341900T3 (pl) 2019-08-30
CN102215835A (zh) 2011-10-12
AU2009304002A1 (en) 2010-04-22
PT2341900T (pt) 2019-05-14
TR201906742T4 (tr) 2019-05-21
CO6341553A2 (es) 2011-11-21
JP2012505830A (ja) 2012-03-08
AU2009304002B2 (en) 2013-04-18
SI2341900T1 (sl) 2019-06-28
GB2476418B (en) 2013-04-24
NZ591496A (en) 2012-12-21
MX340662B (es) 2016-07-20
HRP20190891T1 (hr) 2019-07-12
EP2341900B1 (en) 2019-02-20
MY153932A (en) 2015-04-15
CY1122198T1 (el) 2020-11-25
CA2735834C (en) 2017-05-16
CA2735834A1 (en) 2010-04-22
LT2341900T (lt) 2019-04-10
AU2009304002B9 (en) 2014-06-26
US20110166234A1 (en) 2011-07-07
WO2010044681A1 (en) 2010-04-22
CH702339B1 (de) 2016-06-15
MX2011003928A (es) 2011-08-12
GB201105249D0 (en) 2011-05-11
DK2341900T3 (da) 2019-05-20
BRPI0914086A2 (pt) 2020-01-21
MA32635B1 (fr) 2011-09-01
RU2487707C2 (ru) 2013-07-20
CL2011000678A1 (es) 2011-09-23
GB2476418A (en) 2011-06-22
EP2341900A1 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
CY1125421T1 (el) Ριβονουκλεϊκα οξεα που περιεχουν ν1-μεθυλο- ψευδοουρακιλες και χρησεις αυτων
CY1123552T1 (el) Θεραπειες συνδυασμου με χρηση μοριων προσδεσης psl και pcrv αντι- pseudomonas
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
CY1118680T1 (el) Φαρμακευτικη συνθεση
TR201102810T2 (tr) Tıbbi bir ürün ve tedavi
CY1118874T1 (el) Ανθρωποποιημενα αντισωματα εναντια στη liv-1 και χρηση αυτων για τη θεραπευτικη αντιμετωπιση του καρκινου
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
CR20110658A (es) Antagonistas de la trayectoria hedgehog de ftalazina desustituida
UY34395A (es) ?Tratamiento de Esclerosis Múltiple con la Combinación de Laquinimod y Fingolimod?.
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
CY1121061T1 (el) Αντισωμα enanti-cdh3 που εχει υψηλη ικανοτητα εσωτερικοποιησης
MX2010005244A (es) Composiciones y métodos para la terapia y el diagnóstico de influenza.
CY1113640T1 (el) Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας
CY1118710T1 (el) Συνθεσεις για την θεραπεια της πολλαπλης σκληρυνσης
CY1121167T1 (el) Βελτιωμενα αντισωματα εναντι της ανθρωπινης φρακταλκινης και χρησεις αυτων
CY1114960T1 (el) Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου
EA201490688A1 (ru) 2-тиопиримидиноны
CY1119800T1 (el) Συνδυασμοι υποδοχεα της 5-ητ4 και αναστολεων ακετυλοχολινεστερασης για τη θεραπεια γνωστικων διαταραχων
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
MY161868A (en) Anti-bv8 antibodies and uses thereof
CY1119930T1 (el) Λευκολεκτινες και χρησεις αυτων
CY1114023T1 (el) Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog
EA201201206A1 (ru) Бактерии и их применение
BR112013025630A2 (pt) derivados de piridopirazina e seu uso
BR112014025560A2 (pt) anticorpos anti-pdgf-c